Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study

Abstract Background Scrotal hemorrhage after testicular sperm aspiration (TESA) is uncommon in clinical operation. Phosphodiesterase-5 inhibitors (PDE5i) are commonly given to men who have difficulty providing a sperm sample for assisted reproductive technique such as in vitro fertilization. In this...

Full description

Bibliographic Details
Main Authors: Yong-tong Zhu, Rui Hua, Song Quan, Wan-long Tan, Qing-jun Chu, Chun-yan Wang
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Urology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12894-018-0316-9
_version_ 1818419403879874560
author Yong-tong Zhu
Rui Hua
Song Quan
Wan-long Tan
Qing-jun Chu
Chun-yan Wang
author_facet Yong-tong Zhu
Rui Hua
Song Quan
Wan-long Tan
Qing-jun Chu
Chun-yan Wang
author_sort Yong-tong Zhu
collection DOAJ
description Abstract Background Scrotal hemorrhage after testicular sperm aspiration (TESA) is uncommon in clinical operation. Phosphodiesterase-5 inhibitors (PDE5i) are commonly given to men who have difficulty providing a sperm sample for assisted reproductive technique such as in vitro fertilization. In this study, we examine the incidence of scrotal hemorrhage after TESA in men who received a PDE5i. Methods In this retrospective study, 504 men with TESA operation in Center for Reproductive Medicine, Nanfang Hospital, Southern Medical University were collected. Men in the drug group had taken orally PDE5i before TESA. Men in the control group only operated TESA. The testis volume, coagulation function were measured. Sonographic examination with Doppler imaging was performed when scrotal hemorrhage appeared. Results A total of 504 men with a mean age of 28.63 ± 4.22 years were included in the analysis. Of these, 428 did not receive a PDE5i prior to TESA and 76 received a PDE5i prior to TESA. Measures of coagulation function were not different between the groups. The incidence of hemorrhage was 0.0% in the control group and the drug group was 5.3%. The incidence of hemorrhage between two groups was different significantly (P = 0.000). Conclusion In summary, the results of this study suggest that a PDE5i administration increases the risk of scrotal hemorrhage in men undergoing TESA, although the study design does not allow drawing a conclusion of cause and effect. Given the potential risk of scrotal hemorrhage after the ingestion of PDE5i, it may be wise not to administer it to men in whom a TESA may be performed.
first_indexed 2024-12-14T12:38:01Z
format Article
id doaj.art-a94bf432ee8f4b23917f4b9027b15435
institution Directory Open Access Journal
issn 1471-2490
language English
last_indexed 2024-12-14T12:38:01Z
publishDate 2018-02-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj.art-a94bf432ee8f4b23917f4b9027b154352022-12-21T23:00:59ZengBMCBMC Urology1471-24902018-02-011811410.1186/s12894-018-0316-9Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective studyYong-tong Zhu0Rui Hua1Song Quan2Wan-long Tan3Qing-jun Chu4Chun-yan Wang5Reproductive Medicine Center, Department of Obstetrics and Gynecology, Nanfang Hospital/ The First School of Clinical Medicine, Southern Medical UniversityReproductive Medicine Center, Department of Obstetrics and Gynecology, Nanfang Hospital/ The First School of Clinical Medicine, Southern Medical UniversityReproductive Medicine Center, Department of Obstetrics and Gynecology, Nanfang Hospital/ The First School of Clinical Medicine, Southern Medical UniversityDepartment of Urology, Nanfang Hospital, Southern Medical UniversityReproductive Medicine Center, Department of Obstetrics and Gynecology, Nanfang Hospital/ The First School of Clinical Medicine, Southern Medical UniversityDepartment of Neurology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical UniversityAbstract Background Scrotal hemorrhage after testicular sperm aspiration (TESA) is uncommon in clinical operation. Phosphodiesterase-5 inhibitors (PDE5i) are commonly given to men who have difficulty providing a sperm sample for assisted reproductive technique such as in vitro fertilization. In this study, we examine the incidence of scrotal hemorrhage after TESA in men who received a PDE5i. Methods In this retrospective study, 504 men with TESA operation in Center for Reproductive Medicine, Nanfang Hospital, Southern Medical University were collected. Men in the drug group had taken orally PDE5i before TESA. Men in the control group only operated TESA. The testis volume, coagulation function were measured. Sonographic examination with Doppler imaging was performed when scrotal hemorrhage appeared. Results A total of 504 men with a mean age of 28.63 ± 4.22 years were included in the analysis. Of these, 428 did not receive a PDE5i prior to TESA and 76 received a PDE5i prior to TESA. Measures of coagulation function were not different between the groups. The incidence of hemorrhage was 0.0% in the control group and the drug group was 5.3%. The incidence of hemorrhage between two groups was different significantly (P = 0.000). Conclusion In summary, the results of this study suggest that a PDE5i administration increases the risk of scrotal hemorrhage in men undergoing TESA, although the study design does not allow drawing a conclusion of cause and effect. Given the potential risk of scrotal hemorrhage after the ingestion of PDE5i, it may be wise not to administer it to men in whom a TESA may be performed.http://link.springer.com/article/10.1186/s12894-018-0316-9Scrotal hemorrhageTesticular sperm aspirationPhosphodiesterase-5 inhibitor
spellingShingle Yong-tong Zhu
Rui Hua
Song Quan
Wan-long Tan
Qing-jun Chu
Chun-yan Wang
Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
BMC Urology
Scrotal hemorrhage
Testicular sperm aspiration
Phosphodiesterase-5 inhibitor
title Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
title_full Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
title_fullStr Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
title_full_unstemmed Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
title_short Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
title_sort scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase 5 inhibitor administration a retrospective study
topic Scrotal hemorrhage
Testicular sperm aspiration
Phosphodiesterase-5 inhibitor
url http://link.springer.com/article/10.1186/s12894-018-0316-9
work_keys_str_mv AT yongtongzhu scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy
AT ruihua scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy
AT songquan scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy
AT wanlongtan scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy
AT qingjunchu scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy
AT chunyanwang scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy